Stocks
Intercept Pharmaceuticals (ICPT) Debt/EBITDA US GAAP (year values) |
||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
| Debt/EBITDA | 0.23 | 0.40 | -0.46 | -3.38 | 2.56 | 2.82 | ||
| Changes by years, y/y, % | -127% | +73% | -215% | +629% | -176% | |||
Intercept Pharmaceuticals. Debt/EBITDA
Intercept Pharmaceuticals. Debt/EBITDA, changes, %
Intercept Pharmaceuticals (ICPT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
| Debt/EBITDA | 2.96 | 3.34 | 1.61 | 1.71 | 2.82 | 2.82 | ||
| Changes by years, y/y, % | -232% | -201% | -109% | -120% | -5% | |||
| Changes by quarters, q/q, % | -134% | +13% | -52% | +6% | +65% | |||
